Anti-Colorectal Cancer Activity of Solasonin from Solanum nigrum L. via Histone Deacetylases-Mediated p53 Acetylation Pathway.
Scientists studied Solanum nigrum L., a plant used to treat tumors, and found that its steroidal alkaloid Solasonin (SS) has anti-colorectal cancer (CRC) activity. SS induced apoptosis and cell cycle arrest in CRC cells by downregulating HDAC and increasing P53 acetylation. SS could effectively inhibit CRC growth, making it a potential treatment option.
- Lan X et al (2023).
- Molecules.
- PubMed:
- 37764423